Preprocedural neutrophil count predicts outcome in patients with advanced peripheral vascular disease undergoing percutaneous transluminal angioplasty

Journal of Vascular Surgery

Volumn 48, Issue 6, 2008, Pages 1504-1508

  Toor, Iqbal S ^a   Jaumdally, Rumi J ^a   Moss, Mark S ^a   Babu, Suresh B ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; LEG AMPUTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; NEUTROPHILS; PERIPHERAL VASCULAR DISEASES; POPLITEAL ARTERY; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 57949106457     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.07.072     Document Type: Article

References (31)

1. Wildman R.P., Muntner P., Chen J., Sutton-Tyrrell K., and He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol 96 (2005) 1579-1583
2. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
3. Rosenberg R.D., and Aird W.C. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 340 (1999) 1555-1564
4. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97 (1998) 425-428
5. Ridker P.M., Stampfer M.J., and Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285 (2001) 2481-2485
6. Haugen S., Casserly I.P., Regensteiner J.G., and Hiatt W.R. Risk assessment in the patient with established peripheral arterial disease. Vasc Med 12 (2007) 343-350
7. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112 (2005) 976-983
8. Tzoulaki I., Murray G.D., Price J.F., Smith F.B., Lee A.J., Rumley A., et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol 163 (2006) 334-341
9. Duffy B.K., Gurm H.S., Rajagopal V., Gupta R., Ellis S.G., and Bhatt D.L. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 97 (2006) 993-996
10. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 94;89:36-44.
11. Fuster V. Human lesion studies. Ann N Y Acad Sci 811 (1997) 207-224 discussion 224-205
12. Haumer M., Amighi J., Exner M., Mlekusch W., Sabeti S., Schlager O., et al. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg 41 (2005) 610-617
13. Minar E., Ahmadi A., Koppensteiner R., Maca T., Stumpflen A., Ugurluoglu A., et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 91 (1995) 2167-2173
14. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Censensus (TASC). J Vasc Surg 31 (2000) S1-S296
15. Clark T.W., Groffsky J.L., and Soulen M.C. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 12 (2001) 923-933
16. Gurm H.S., Bhatt D.L., Lincoff A.M., Tcheng J.E., Kereiakes D.J., Kleiman N.S., et al. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials. Heart 89 (2003) 1200-1204
17. Gurm H.S., Bhatt D.L., Gupta R., Ellis S.G., Topol E.J., and Lauer M.S. Preprocedural white blood cell count and death after percutaneous coronary intervention. Am Heart J 146 (2003) 692-698
18. Rajagopal V., Gurm H.S., Bhatt D.L., Lincoff A.M., Tcheng J.E., Kereiakes D.J., et al. Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality. Am J Cardiol 94 (2004) 190-192
19. Belch J.J., Sohngen M., Robb R., Voleske P., and Sohngen W. Neutrophil count and amputation in critical limb ischaemia. Int Angiol 18 (1999) 140-144
20. Shishehbor M.H., and Bhatt D.L. Inflammation and atherosclerosis. Curr Atheroscler Rep 6 (2004) 131-139
21. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
22. Lee C.D., Folsom A.R., Nieto F.J., Chambless L.E., Shahar E., and Wolfe D.A. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol 154 (2001) 758-764
23. Kannel W.B., Anderson K., and Wilson P.W. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 267 (1992) 1253-1256
24. Bovill E.G., Bild D.E., Heiss G., Kuller L.H., Lee M.H., Rock R., et al. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. Am J Epidemiol 143 (1996) 1107-1115
25. Biasucci L.M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., et al. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 27 (1996) 611-616
26. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
27. Dinerman J.L., Mehta J.L., Saldeen T.G., Emerson S., Wallin R., Davda R., et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 15 (1990) 1559-1563
28. Fu X., Kassim S.Y., Parks W.C., and Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276 (2001) 41279-41287
29. Engler R.L., Schmid-Schonbein G.W., and Pavelec R.S. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111 (1983) 98-111
30. Schmid-Schonbein G.W. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 46 (1987) 2397-2401
31. Hickman P., McCollum P.T., and Belch J.J. Neutrophils may contribute to the morbidity and mortality of claudicants. Br J Surg 81 (1994) 790-798